1European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol,2009, 51:237-267. 被引量：1
2Manns MP, Czaja A J, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology,2010,51:2193-2213. 被引量：1
3Alvarez F, Berg PA, Bianehi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepati- tis. J Hepatol,1999,31:929-938. 被引量：1
5SHI J, WU C, LIN Y, et al. Long-term effects of mid- dose ursodeoxycholic acid in primary biliary cirrhosis: a meta - analysis of randomized controlled trials [ J ]. Am J Gastro- enterol, 2006, 101 (7} 1529-1538. 被引量：1
6CHUANG YH, LIAN ZX, TSUNEYAMA K, et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis [ J ]. J Autoimmun, 2006, 26(4) : 232 -240. 被引量：1
7SHIMODA S, HARADA K, NIIRO H, et al. CX3CL1 (fracta- Ikine) : a signpost for biliary inflammation in primary biliary cir- rhosis[J]. Hepatology, 2010, 51(2): 567-575. 被引量：1
8SHIMODA S, HARADA K, NIIRO H, et al. Interaction be- tween Toll - like receptors and natural killer cells in the de- struction of bile ducts in primary biliary cirrhosis J ]. Hepa- tology, 2011, 53(4): 1270-1281. 被引量：1
9TIAN Z, GERSHWIN ME, ZHANG C. Regulatory NK cells in autoimmune disease[J]. J Autoimmun, 2012, 39(3) : 206 -215. 被引量：1
10MAO TK, LIAN ZX, SELMI C, et al. Altered monocyte re- sponses to defined TLR ligands in patients with primary biliary cirrhosis[J]. Hepatology, 2005, 42(4): 802-808. 被引量：1
